Dysfunction in the hip joints in children with Charcot-Marie-Tooth syndrome (literature review)

Cover Page

Abstract


A review of the literature on the treatment of children with dysfunction in the hip joints in motor-sensory neuropathy Charcot-Marie-Tooth is presented. Peculiarities of disease diagnosis and the approach used in the treatment of patients are described. The Charcot-Marie-Tooth syndrome is a hereditary neuromuscular disease characterized by progressive atrophy of the distal muscle group of the lower limbs. According to international authors, the incidence of hip joint dysfunction in this condition is at least 10%, ranking second only to foot deformities. In the Russian literature, the problem has not been adequately interpreted. Early diagnosis of dysfunction in the hip joints during Charcot-Marie-Tooth syndrome is complicated by the child's age and is characterized by progression. Conflicting clinical signs and trivial symptoms of the disease also confuse diagnosis, until it becomes clearer in adolescence or the second or third decade of life. Surgical reconstructive operations on the hip joint often occur too late, and they are accompanied by a greater frequency of neurological complications. Practitioner awareness coupled with an early diagnosis of hip subluxation and decentration and complex orthopedic and neurological examinations of children with the disease of Charcot-Marie-Tooth should result in more favorable outcomes.

Ivan Yurievich Pozdnikin

The Turner Institute for Children’s Orthopedics, Saint-Petersburg, Russian Federation

Email: pozdnikin@gmail.com
MD, PhD, research associate of the department of hip pathology. The Turner Scientific and Research Institute for Children’s Orthopedics

  1. Бадалян Л. О. Невропатология: учебник для студ. вузов. - 5-е изд., стер. - М.: Академия, 2008. - 400 с.
  2. Вельтищев Ю.С. Наследственные болезни нервной системы. - М.: Медицина, 1998. - 496 с.
  3. Дадали Е.Л. Наследственные нервно-мышечные заболевания: диагностика и медико-генетическое консультирование: автореф. дис. д-ра мед. наук - М., 1999. - 35 с.
  4. Левин О.С. Полиневропатии. - М.: Медицинское информационное агентство, 2006. - 491 c.
  5. Петрухин А.С. Неврология детского возраста. - М.: Медицина, 2004. - 783 с.
  6. Яхно H.H. Болезни нервной системы: руководство для врачей. - М.: Медицина, 2001. - 1224 с.
  7. Berciano J, GarcÃ-a A, Combarros O. Initial semeiology in children with Charcot-Marie-Tooth disease 1A duplication. Muscle Nerve. 2002;27(1):34-9. doi: 10.1002/mus.10299.
  8. Berghoff C, Berghoff M, Leal A, et al. Clinical and electrophysiological characteristics of autosomal recessive axonal Charcot-Marie-Tooth disease (ARCMT2B) that maps to chromosome 19ql3.3. Neuromuscul Disord. 2004;14:301-306. doi: 10.1016/j.nmd.2004.02.004.
  9. Nelis E, Erdem S, Van den Bergh PYK, et al. Autosomal recessive CMT with demyelination and axonopathy. Neurology. 2002;59:1865-1872. doi: 10.1212/01.wnl.0000036272.36047.54.
  10. Street VA, Goldy JD, Golden AS, et al. Mapping of Charcot-Marie-Tooth disease Type 1C to chromosome 16p identifies a novel locus for demyelinating neuropathy. Am J Hum Genet. 2002;70:244-250. doi: 10.1086/337943.
  11. Tang BS, Luo W, Xia K, et al. A new locus for autosomal dominant Charcot-Marie-Tooth disease type 2 (CMT2L) maps to chromosome 12q24. Hum Genet. 2004;114:527-533. doi: 10.1007/s00439-004-1102-1.
  12. Noto Y. Ultrasound diagnosis of Charcot-Marie-Tooth disease. Brain Nerve. 2014;66(3):237-46.
  13. Rossor AM, Polke JM, Houlden H, Reilly MM. Clinical implications of genetic advances in Charcot-Marie-Tooth disease. Nat Rev Neurol. 2013;9(10):562-71. doi: 10.1038/nrneurol.2013.179.
  14. Vallat JM, Mathis S, Funalot B. The various Charcot-Marie-Tooth diseases. Curr Opin Neurol. 2013;26(5): 473-80. doi: 10.1097/wco.0b013e328364c04b.
  15. Li J. Inherited Neuropathies. Semin. Neurol. 2012;32(3): 204-214. doi: 10.1055/s-0032-1329198.
  16. Mersyanova IV, Perepelov AV, Polyakov AV, et al. A new variant of Charcot-Marie-Tooth Disease type 2 is probably the result of a mutation in the neurofilament-light gene. Am J Hum Genet. 2000;67:37-46. doi: 10.1086/302962.
  17. Harding AE. From the syndrome of Charcot, Marie and Tooth to disorders of peripheral myelin proteins. Brain. 1995;118(3):809-18. Review. doi: 10.1093/brain/118.3.809.
  18. McMillan JC, Harper PS. The Charcot-Marie-Tooth syndrome: clinical aspects from a population study in South Wales. UK Clin Genet 1994;45:128-134. doi: 10.1111/j.1399-0004.1994.tb04009.x.
  19. Kamholz J, Menichella D, Jani A, et al. Charcot-Marie-Tooth disease type 1. Molecular pathogenesis to gene therapy. Brain. 2000;123:222-233. doi: 10.1093/brain/123.2.222.
  20. Bird TD. Charcot-Marie-Tooth hereditary neuropathy overview. In: Pagon RA, Adam MP, Ardinger HH, et al. Gene Reviews at Gene Tests: Medical Genetics Information Resource. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2014. 1998 Sep 28 [updated 2014 Mar 06]. Available at http://www.genetests.org.
  21. Gemignani F, Melli G, Alfieri S, et al. Sensory manifestations in Charcot-Marie-Tooth disease. J Peripher Nerv Syst. 2004;9:7-14. doi: 10.1111/j.1085-9489.2004.09103.x.
  22. Herring JA. Tachdjian’s pediatric orthopaedics, 5rd ed. CHAPTER 23 - Disorders of the Foot P. 761-864; CHAPTER 38 - Disorders of the Peripheral Nervous System P. 285-319; CHAPTER 41 - Orthopaedic-Related Syndromes P. 473-581. Philadelphia: Saunders Elsevier, 2013.
  23. Kang JH, Kim HJ, Lee ER. Electrophysiological evaluation of chronic inflammatory demyelinating polyneuropathy and Charcot-Marie-Tooth Type 1: dispersion and correlation analysis. J Phys Ther Sci. 2013;25: 1265-1268. doi: 10.1589/jpts.25.1265.
  24. Kumar SJ, Marks HG, Bowen JR, MacEwen GD. Hip dysplasia associated with Charcot-Marie-Tooth disease in the older child and adolescent. J Pediatr Orthop. 1985;5:511-14. doi: 10.1097/01241398-198509000-00001.
  25. Bamford NS, White KK, Robinett SA, et al. Neuromuscular hip dysplasia in Charcot-Marie-Tooth disease type 1A. Developmental Medicine & Child Neurology. 2009;51(5):408-411. doi: 10.1111/j.1469-8749.2008.03234.x.
  26. Chan G, Bowen JR, Kumar SJ. Evaluation and treatment of hip dysplasia in Charcot-Marie-Tooth disease. Orthop Clin North Am. 2006;37:203-09. doi: 10.1016/j.ocl.2005.12.002.
  27. Fuller JE, De Luca PA. Acetabular dysplasia and Charcot-MarieTooth disease in a family. A report of four cases. J Bone Joint Surg Am. 1995;77:1087-91.
  28. McGann R, Gurd A. The association between Charcot-Marie-Tooth disease and developmental dysplasia of the hip. Orthopedics. 2002;25:337-39.
  29. Pailthorpe CA, Benson MK. Hip dysplasia in hereditary motor and sensory neuropathies. J Bone Joint Surg Br. 1992;74:538.
  30. Cucuzzella TR, Guille JT, MacEwen GD. Charcot-Marie-Tooth disease associated with hip dysplasia: a case report. Del Med J. 1996;68:305-07.
  31. Ushiyama T, Tanaka C, Kawasaki T, Matsusue Y. Hip dysplasia in Charcot-Marie-Tooth disease: report of a family. J Orthop Sci. 2003;8:610-12. doi: 10.1007/s00776-003-0669-z.
  32. Van Erve RH, Driessen AP. Developmental hip dysplasia in hereditary motor and sensory neuropathy type 1. J Pediatr Orthop. 1999;19:92-96. doi: 10.1097/01241398-199901000-00021.
  33. Driscoll SW, Skinner J. Musculoskeletal complications of neuromuscular disease in children. Phys Med Rehabil Clin N Am. 2008;19:163-94. doi: 10.1016/j.pmr.2007.10.003.
  34. Shy ME. Hereditary neuropathies. In: Rowland LP, editor. Merrittes neurology. 11th ed. Philadelphia: Lippincott William and Wilkins; 2005;738-47.
  35. Поздникин Ю.И., Камоско М.М., Краснов А.И., и др. Система лечения дисплазии тазобедренного сустава и врожденного вывиха бедра как основа профилактики диспластического коксартроза // Вестник травматологии и ортопедии им. Н. Н. Приорова. - 2007. - №3. - С. 63-71.
  36. Novais EN, Bixby SD, Rennick J, et al. Hip dysplasia is more severe in Charcot-Marie-Tooth disease than in developmental dysplasia of the hip. Clin Orthop Relat Res. 2013;472(2):665-73. doi: 10.1007/s11999-013-3127-z.
  37. Walker JL, Nelson KR, Heavilon JA, et al. Hip abnormalities in children with Charcot-Marie-Tooth disease. J Pediatr Orthop. 1994;14:54-59. doi: 10.1097/01241398-199401000-00012.
  38. Newman CJ, Walsh M, O’Sullivan R, et al. The characteristics of gait in Charcot-Marie-Tooth disease types I and II. Gait Posture. 2007;26:120-27. doi: 10.1016/j.gaitpost.2006.08.006.
  39. Chan G, Sampath J, Miller F, et al. The role of the dynamic pedobarograph in assessing treatment of cavovarus feet in children with Charcot-Marie-Tooth disease. J Pediatr Orthop. 2007;27:510-516. doi: 10.1097/bpo.0b013e318070cbe8.
  40. Hadianfard MJ, Ashraf A. Hip dysplasia associated with a hereditary sensorimotor polyneuropathy mimics a myopathic process. Ann Indian Acad Neurol. 2012;15(3):211-213. doi: 10.4103/0972-2327.99722.
  41. Trumble SJ, Mayo KA, Mast JW. The periacetabular osteotomy. Minimum 2 year follow-up in more than 100 hips. Clin Orthop Relat Res. 1999:54-63. doi: 10.1097/00003086-199906000-00008.
  42. Stover MD, Podeszwa DA, De La Rocha A, Sucato DJ. Early results of the Bernese periacetabular osteotomy for symptomatic dysplasia in Charcot-Marie-Tooth disease. Hip Int. 2013; 23(9):2-7. doi: 10.5301/hipint.5000061.
  43. Thawrani D, Sucato DJ, Podeszwa DA, et al.Complications associated with the Bernese periacetabular osteotomy for hip dysplasia in adolescents. J Bone Joint Surg Am. 2010;92:1707. doi: 10.2106/jbjs.i.00829.

Views

Abstract - 685

PDF (Russian) - 315

PDF (English) - 312

PlumX


Copyright (c) 2015 Pozdnikin I.Y.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.